• Has over 25 years of experience in drug discovery in the biopharmaceutical industry

• Served as senior research scientist at Gilead Sciences, Inc.

• Served as associate director of chemical research at Pharmasset Inc.

• During his employment at Pharmasset, Dr. Du, as one of the inventors, participated in the R&D of sofosbuvir (also known as sovaldi), a revolutionary drug for treating hepatitis C which won the Prix Galien Award granted by the Galien Foundation in 2014

• In Jan. 2012, Gilead Sciences, Inc. completed the acquisition of Pharmasset Inc. for about USD 11.2 billion, and  thereby obtained sofosbuvir

• Has published 60 academic papers and participated in the invention of more than 300 patents registered worldwide, of which 40 patents had been licensed in the United States

• Has nearly 30 years of experience in R&D and management in the biopharmaceutical industry

• Served as the vice president of CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., a wholly owned subsidiary of CSPC Pharmaceutical Group Limited, and the vice president of Qilu Pharmaceutical Co., Ltd.

• Served as the Asia head of external innovation for endocrine and cardiovascular system at the Lilly China R&D Center of Eli Lilly and Company

• Served as director of foreign cooperative chemical projects at Merck Sharp & Dohme Corp. and director of medicinal chemistry at Metabasis Therapeutics, Inc.

• Participated in the R&D of various drugs and drug candidates for clinical use, including a first generation and a second generation FBPase inhibitor for the treatment of type II diabetes

• Dual doctor of Medicine and Science

• Has over 20 years of experience in medical and clinical research

• Worked at University of Virginia Health System in the United States

• Served as a physician and the international medical center director of Shenzhen Vista-SK International Medical Center

• Has over 21 years of experience in the R&D of innovative drugs; particularly, has extensive R&D experience in novel drug

• Served as the vice general manager of Shanghai Yishi Medical Technology Co., Ltd., a subsidiary of CSPC Pharmaceutical Group Limited

• Served as the executive officer of medicinal chemistry department at Adlai Nortye Biopharma Co., Ltd.

• Served as the principal researcher at Vertex Pharmaceuticals, Inc.